• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • Login
  • 0Shopping Cart

  • COVID-19 Resources
  • Blog
  • Featured
    • View Webinars On-Demand
    • The In Vitro Diagnostics Market: $83 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • Free Downloads
  • About Us
  • Research Index
  • Contact
  • Search
  • Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology
  • Diagnostics
  • Healthcare
  • Medical Devices
  • Pharmaceuticals

Most Popular Research

  • The Worldwide Market for In Vitro Diagnostics, 13th Edition
  • Clinical Diagnostics MasterFile
  • Benchmarking for 2021: Understanding the Clinical Diagnostics Customer Experience
  • Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
  • The Market and Future Potential for Molecular Point of Care
    $3,600.00 – $7,200.00
    This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular […]
    January 22, 2021
  • IVD Procedure Volumes 2020-2025
    $3,600.00 – $7,200.00
    In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of the both the existing number of procedures for […]
    January 19, 2021
  • Genetic Testing Markets for Epilepsy, Autism, Alzheimer's and Other Neurologic Conditions
    $3,600.00 – $7,200.00
    Genetic involvement in the pathogenesis of neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases.  Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes […]
    January 4, 2021
  • Single Cell Genomics Markets
    $4,950.00 – $9,900.00
    The study of individual cells has long been an important part of biological research.  Historically this has been a very manual process; some automated technologies are available.  The need for microscopy and other traditional methods has remained, as new methods have also arrived, all of which have been gradually improved.  The ability to amplify DNA […]
    December 23, 2020
  • Vaccines 2020: World Market Analysis, Players, Trends
    $4,000.00 – $8,000.00
    Vaccine Market Tops 37 Billion, Says Kalorama Information Report In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information’s report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025. THE MOST CURRENT VACCINE MARKET […]
    November 4, 2020
  • COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets
    $4,000.00 – $8,000.00
    COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis […]
    November 2, 2020
  • Sepsis Diagnostics Products and Market Trends
    $3,000.00 – $6,000.00
    The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently.  In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths.  Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals.   This report provides comprehensive […]
    October 26, 2020
  • The Market for Clinical LDT Services and LDT Supplies
    $5,500.00 – $11,000.00
    Laboratory developed tests (LDTs) are not a new or recent phenomenon but due to the incredible need for testing of SARS-CoV-2, there has been a flood of new tests and the regulatory guidance has changed dramatically.  Historically, these tests were called “home-brew tests” or “in-house tests.”  Also, historically, these tests were low-volume, simple and well […]
    September 24, 2020
  • The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales)
    $5,500.00 – $11,000.00
    What is the Market for Urgent Care Centers?  What Services are they Selling?  Who is Selling Testing and Vaccine Products to Urgent Care? Kalorama’s comprehensive report answers these questions, and more. With approximately 10,000 locations across the country, urgent care clinics (UCCs), are an increasingly important of the U.S. health care marketplace. They offer walk-in […]
    September 18, 2020
  • The Market for RNA Sequencing
    $5,500.00 – $11,000.00
    The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of […]
    August 24, 2020
Page 1 of 77123›»

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • COVID-19 Pandemic Accelerates Adoption of Diagnostic Testing at Point of Care January 12, 2021
  • Science and Medicine Groups Predictions for 2021 in the Lab Instrumentation, Diagnostics and Imaging Industries January 7, 2021
  • For Roche, Alignment Between Tests and COVID-19 Vaccines is Key December 14, 2020
  • Lab Industry Voices, Diagnostic Innovation, and Ugly Sweater Parties: What We’ll be Watching at #2020AACC December 14, 2020
  • COVID-19 Diagnostics Blog: Thermo Combo Test CE Marked; Roche Antibody Test Earns EUA – In Time for Vaccines; Antigen Testing A Focus December 7, 2020

Sitemap

  • Home
  • About
  • Blog
  • Contact

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Scroll to top
Register for Access Login for Access

Register for Access Login for Access

Lost your password? Register